, Volume 69, Issue 8, pp 971–986 | Cite as

Diabetic Gastroparesis

Diagnosis and Management
  • Jing Ma
  • Christopher K. RaynerEmail author
  • Karen L. Jones
  • Michael Horowitz
Review Article


Gastric emptying is frequently abnormal in patients with long-standing type 1 and type 2 diabetes mellitus. Symptoms commonly associated with disordered gastric emptying include nausea, vomiting, bloating and epigastric pain, while patients are also at risk of malnutrition, weight loss, impaired drug absorption, disordered glycaemic control and poor quality of life. Although often attributed to the presence of irreversible autonomic neuropathy, acute hyperglycaemia represents a potentially reversible cause of gastric dysfunction in diabetes. Scintigraphy represents the gold standard for measuring gastric emptying. The management of diabetic gastroparesis is less than optimal, partly because the pathogenesis has not been clearly defined. Treatment approaches include dietary modification and optimization of glycaemia, and the use of prokinetic drugs, while novel therapies such as gastric electrical stimulation are the subject of ongoing investigation.


Gastric Emptying Cisapride Functional Dyspepsia Gastroparesis Domperidone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors’ research work was been supported by the National Health and Medical Research Council of Australia, the Royal Adelaide Hospital/Institute of Medical and Veterinary Science Research Committee, and the Rebecca L. Cooper Foundation. Dr Horowitz has been a member of advisory boards of Tranzyme Pharma, Amulet Pharma and Merck Sharpe & Dohme, and has received honoraria for these activities. The other authors have no conflicts of interest that are directly relevant to the content of this review.


  1. 1.
    Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127(5): 1592–622PubMedCrossRefGoogle Scholar
  2. 2.
    Wang YR, Fisher RS, Parkman HP. Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995–2004. Am J Gastroenterol 2008; 103(2): 313–22PubMedCrossRefGoogle Scholar
  3. 3.
    Abell TL, Bernstein RK, Cutts T, et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 2006; 18(4): 263–83PubMedCrossRefGoogle Scholar
  4. 4.
    Camilleri M. Clinical practice. Diabetic gastroparesis. N Engl J Med 2007; 356(8): 820–9Google Scholar
  5. 5.
    Schvarcz E, Palmer M, Ingberg CM, et al. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet Med 1996; 13(5): 478–81PubMedCrossRefGoogle Scholar
  6. 6.
    Ricci JA, Siddique R, Stewart WF, et al. Upper gastrointestinal symptoms in a US national sample of adults with diabetes. Scand J Gastroenterol 2000; 35(2): 152–9PubMedCrossRefGoogle Scholar
  7. 7.
    Horowitz M, Maddox AF, Wishart JM, et al. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med 1991; 18(4): 229–34PubMedCrossRefGoogle Scholar
  8. 8.
    Ferroir J. The diabetic stomach. Thesis in medicine. Paris, France, 1937Google Scholar
  9. 9.
    Horowitz M, Wishart JM, Jones KL, et al. Gastric emptying in diabetes: an overview. Diabet Med 1996; 13 (9 Suppl. 5): S16–22PubMedGoogle Scholar
  10. 10.
    Horowitz M, Su YC, Rayner CK, et al. Gastroparesis: prevalence, clinical significance and treatment. Can J Gastroenterol 2001; 15(12): 805–13PubMedGoogle Scholar
  11. 11.
    Jones KL, Horowitz M, Wishart MJ, et al. Relationships between gastric emptying, intragastric meal distribution and blood glucose concentrations in diabetes mellitus. J Nucl Med 1995; 36(12): 2220–8PubMedGoogle Scholar
  12. 12.
    Moldovan C, Dumitrascu DL, Demian L, et al. Gastroparesis in diabetes mellitus: an ultrasonographic study. Rom J Gastroenterol 2005; 14(1): 19–22PubMedGoogle Scholar
  13. 13.
    Phillips WT, Schwartz JG, McMahan CA. Rapid gastric emptying of an oral glucose solution in type 2 diabetic patients. J Nucl Med 1992; 33(8): 1496–500PubMedGoogle Scholar
  14. 14.
    Jones KL, Horowitz M, Carney BI, et al. Gastric emptying in early noninsulin-dependent diabetes mellitus. J Nucl Med 1996; 37(10): 1643–8PubMedGoogle Scholar
  15. 15.
    Nowak TV, Johnson CP, Kalbfleisch JH, et al. Highly variable gastric emptying in patients with insulin dependent diabetes mellitus. Gut 1995; 37(1): 23–9PubMedCrossRefGoogle Scholar
  16. 16.
    Horowitz M, Jones KL, Akkermans LM, et al. Gastric function. In: Horowitz M, Samsom M, editors. Gastrointestinal function in diabetes mellitus. Chichester: John Wiley & Sons Ltd, 2004: 117–76CrossRefGoogle Scholar
  17. 17.
    Horowitz M, Dent J, Fraser R, et al. Role and integration of mechanisms controlling gastric emptying. Dig Dis Sci 1994; 39 (12Suppl.): 7–13SCrossRefGoogle Scholar
  18. 18.
    Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology 2006; 131(2): 640–58PubMedCrossRefGoogle Scholar
  19. 19.
    Samsom M, Roelofs JM, Akkermans LM, et al. Proximal gastric motor activity in response to a liquid meal in type I diabetes mellitus with autonomic neuropathy. Dig Dis Sci 1998; 43(3): 491–6PubMedCrossRefGoogle Scholar
  20. 20.
    Samsom M, Salet GA, Roelofs JM, et al. Compliance of the proximal stomach and dyspeptic symptoms in patients with type I diabetes mellitus. Dig Dis Sci 1995; 40(9): 2037–42PubMedCrossRefGoogle Scholar
  21. 21.
    Samsom M, Jebbink RJ, Akkermans LM, et al. Abnormalities of antroduodenal motility in type I diabetes. Diabetes Care 1996; 19(1): 21–7PubMedCrossRefGoogle Scholar
  22. 22.
    Wehrmann T, Lembcke B, Caspary WF. Influence of cisapride on antroduodenal motor function in healthy subjects and diabetics with autonomic neuropathy. Aliment Pharmacol Ther 1991; 5(6): 599–608PubMedCrossRefGoogle Scholar
  23. 23.
    Kawagishi T, Nishizawa Y, Okuno Y, et al. Antroduodenal motility and transpyloric fluid movement in patients with diabetes studied using duplex sonography. Gastroenterology 1994; 107(2): 403–9PubMedGoogle Scholar
  24. 24.
    Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90(6): 1919–25PubMedGoogle Scholar
  25. 25.
    Koch KL. Electrogastrography: physiological basis and clinical application in diabetic gastropathy. Diabetes Technol Ther 2001; 3(1): 51–62PubMedCrossRefGoogle Scholar
  26. 26.
    Nohara S, Iwase M, Imoto H, et al. Gastric emptying in patients with type 2 diabetes mellitus and diabetes associated with mitochondrial DNA 3243 mutation using 13C-octanoic acid breath test. J Diabetes Complications 2006; 20(5): 295–301PubMedCrossRefGoogle Scholar
  27. 27.
    Kumar A, Attaluri A, Hashmi S, et al. Visceral hypersensitivity and impaired accommodation in refractory diabetic gastroparesis. Neurogastroenterol Motil 2008; 20(6): 635–42PubMedCrossRefGoogle Scholar
  28. 28.
    Rayner CK, Verhagen MA, Hebbard GS, et al. Proximal gastric compliance and perception of distension in type 1 diabetes mellitus: effects of hyperglycemia. Am J Gastroenterol 2000; 95(5): 1175–83PubMedCrossRefGoogle Scholar
  29. 29.
    Rayner CK, Horowitz M. Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited? J Clin Invest 2006; 116(2): 299–302PubMedCrossRefGoogle Scholar
  30. 30.
    Schmidt RE. Neuropathology and pathogenesis of diabetic autonomic neuropathy. Int Rev Neurobiol 2002; 50: 257–92PubMedCrossRefGoogle Scholar
  31. 31.
    Schmidt RE, Plurad SB, Olack BJ, et al. The effect of pancreatic islet transplantation and insulin therapy on experimental diabetic autonomic neuropathy. Diabetes 1983; 32(6): 532–40PubMedCrossRefGoogle Scholar
  32. 32.
    Horvath VJ, Vittal H, Ordog T. Reduced insulin and IGF-I signaling, not hyperglycemia, underlies the diabetes-associated depletion of interstitial cells of Cajal in the murine stomach. Diabetes 2005; 54(5): 1528–33PubMedCrossRefGoogle Scholar
  33. 33.
    Horvath VJ, Vittal H, Lorincz A, et al. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis. Gastroenterology 2006; 130(3): 759–70PubMedCrossRefGoogle Scholar
  34. 34.
    Watkins CC, Sawa A, Jaffrey S, et al. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest 2000; 106(3): 373–84PubMedCrossRefGoogle Scholar
  35. 35.
    Gangula PR, Maner WL, Micci MA, et al. Diabetes induces sex-dependent changes in neuronal nitric oxide synthase dimerization and function in the rat gastric antrum. Am J Physiol Gastrointest Liver Physiol 2007; 292(3): G725–33PubMedCrossRefGoogle Scholar
  36. 36.
    Asakawa H, Onishi M, Hayashi I, et al. Comparison between coefficient of R-R interval variation and gastric emptying in type 2 diabetes mellitus patients. J Gastroenterol Hepatol 2005; 20(9): 1358–64PubMedCrossRefGoogle Scholar
  37. 37.
    Yoshida MM, Schuffler MD, Sumi SM. There are no morphologic abnormalities of the gastric wall or abdominal vagus in patients with diabetic gastroparesis. Gastroenterology 1988; 94(4): 907–14PubMedGoogle Scholar
  38. 38.
    Forster J, Damjanov I, Lin Z, et al. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg 2005; 9(1): 102–8PubMedCrossRefGoogle Scholar
  39. 39.
    Pasricha PJ, Pehlivanov ND, Gomez G, et al. Changes in the gastric enteric nervous system and muscle: a case report on two patients with diabetic gastroparesis. BMC Gastroenterol 2008; 8: 21PubMedCrossRefGoogle Scholar
  40. 40.
    Ejskjaer NT, Bradley JL, Buxton-Thomas MS, et al. Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med 1999; 16(6): 488–95PubMedCrossRefGoogle Scholar
  41. 41.
    Rayner CK, Samsom M, Jones KL, et al. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001; 24(2): 371–81PubMedCrossRefGoogle Scholar
  42. 42.
    Fraser RJ, Horowitz M, Maddox AF, et al. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33(11): 675–80PubMedCrossRefGoogle Scholar
  43. 43.
    Schvarcz E, Palmer M, Aman J, et al. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology 1997; 113(1): 60–6PubMedCrossRefGoogle Scholar
  44. 44.
    Russo A, Stevens JE, Chen R, et al. Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes. J Clin Endocrinol Metab 2005; 90(8): 4489–95PubMedCrossRefGoogle Scholar
  45. 45.
    Schvarcz E, Palmer M, Aman J, et al. Hypoglycemia increases the gastric emptying rate in healthy subjects. Diabetes Care 1995; 18(5): 674–6PubMedCrossRefGoogle Scholar
  46. 46.
    Schvarcz E, Palmer M, Aman J, et al. Hypoglycaemia increases the gastric emptying rate in patients with type 1 diabetes mellitus. Diabet Med 1993; 10(7): 660–3PubMedCrossRefGoogle Scholar
  47. 47.
    Hasler WL, Soudah HC, Dulai G, et al. Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gastroenterology 1995; 108(3): 727–36PubMedCrossRefGoogle Scholar
  48. 48.
    Jebbink RJ, Samsom M, Bruijs PP, et al. Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type I diabetes mellitus. Gastroenterology 1994; 107(5): 1390–7PubMedGoogle Scholar
  49. 49.
    Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology 1988; 94(3): 739–44PubMedGoogle Scholar
  50. 50.
    Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1989; 32(3): 151–9PubMedCrossRefGoogle Scholar
  51. 51.
    Gallar P, Oliet A, Vigil A, et al. Gastroparesis: an important cause of hospitalization in continuous ambulatory peritoneal dialysis patients and the role of erythromycin. Perit Dial Int 1993; 13 Suppl. 2: S183–6PubMedGoogle Scholar
  52. 52.
    Bell RA, Jones-Vessey K, Summerson JH. Hospitalizations and outcomes for diabetic gastroparesis in North Carolina. South Med J 2002; 95(11): 1297–9PubMedGoogle Scholar
  53. 53.
    Whitson BA, Asolati M, Kandaswamy R, et al. Diabetic gastroparesis-associated bezoar resolution via ‘cola-lysis’. Clin Transplant 2008; 22(2): 242–4PubMedCrossRefGoogle Scholar
  54. 54.
    Horowitz M, O’Donovan D, Jones KL, et al. Gastric emptying in diabetes: clinical significance and treatment. Diabet Med 2002; 19(3): 177–94PubMedCrossRefGoogle Scholar
  55. 55.
    Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15 000 adults. Arch Intern Med 2001; 161(16): 1989–96PubMedCrossRefGoogle Scholar
  56. 56.
    Jones KL, Russo A, Stevens JE, et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care 2001; 24(7): 1264–9PubMedCrossRefGoogle Scholar
  57. 57.
    Quan C, Talley NJ, Jones MP, et al. Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol 2008; 20(9): 888–97PubMedCrossRefGoogle Scholar
  58. 58.
    Talley SJ, Bytzer P, Hammer J, et al. Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001; 96(4): 1033–8PubMedCrossRefGoogle Scholar
  59. 59.
    Koch CA, Uwaifo GI. Are gastrointestinal symptoms related to diabetes mellitus and glycemic control? Eur J Gastroenterol Hepatol 2008; 20(9): 822–5PubMedCrossRefGoogle Scholar
  60. 60.
    Horowitz M, Edelbroek MA, Wishart JM, et al. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 1993; 36(9): 857–62PubMedCrossRefGoogle Scholar
  61. 61.
    Chaikomin R, Doran S, Jones KL, et al. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects. Am J Physiol Endocrinol Metab 2005; 289(3): E504–7PubMedCrossRefGoogle Scholar
  62. 62.
    O’Donovan DG, Doran S, Feinle-Bisset C, et al. Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes. J Clin Endocrinol Metab 2004; 89(7): 3431–5PubMedCrossRefGoogle Scholar
  63. 63.
    Gonlachanvit S, Hsu CW, Boden GH, et al. Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients. Dig Dis Sci 2003; 48(3): 488–97PubMedCrossRefGoogle Scholar
  64. 64.
    Ishii M, Nakamura T, Kasai F, et al. Altered postprandial insulin requirement in IDDM patients with gastroparesis. Diabetes Care 1994; 17(8): 901–3PubMedCrossRefGoogle Scholar
  65. 65.
    Horowitz M, Jones KL, Rayner CK, et al. ‘Gastric’ hypoglycaemia: an important concept in diabetes management. Neurogastroenterol Motil 2006; 18(6): 405–7PubMedCrossRefGoogle Scholar
  66. 66.
    Ohlsson B, Melander O, Thorsson O, et al. Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasis. Diabetologia 2006; 49(9): 2010–4PubMedCrossRefGoogle Scholar
  67. 67.
    Chandalia M, Garg A, Lutjohann D, et al. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 2000; 342(19): 1392–8PubMedCrossRefGoogle Scholar
  68. 68.
    Russo A, Stevens JE, Wilson T, et al. Guar attenuates fall in postprandial blood pressure and slows gastric emptying of oral glucose in type 2 diabetes. Dig Dis Sci 2003; 48(7): 1221–9PubMedCrossRefGoogle Scholar
  69. 69.
    Gentilcore D, Chaikomin R, Jones KL, et al. Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes. J Clin Endocrinol Metab 2006; 91(6): 2062–7PubMedCrossRefGoogle Scholar
  70. 70.
    Cunningham KM, Read NW. The effect of incorporating fat into different components of a meal on gastric emptying and postprandial blood glucose and insulin responses. Br J Nutr 1989; 61(2): 285–90PubMedCrossRefGoogle Scholar
  71. 71.
    Cervera A, Wajcberg E, Sriwijitkamol A, et al. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes. Am J Physiol Endocrinol Metab 2008; 294(5): E846–52PubMedCrossRefGoogle Scholar
  72. 72.
    Linnebjerg H, Park S, Kothare PA, et al. Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes. Regul Pept 2008; 151(1–3): 123–9PubMedCrossRefGoogle Scholar
  73. 73.
    Hebbard GS, Sun WM, Bochner F, et al. Pharmacokinetic considerations in gastrointestinal motor disorders. Clin Pharmacokinet 1995; 28(1): 41–66PubMedCrossRefGoogle Scholar
  74. 74.
    Groop LC, Luzi L, DeFronzo RA, et al. Hyperglycaemia and absorption of sulphonylurea drugs. Lancet 1989; II(8655): 129–30CrossRefGoogle Scholar
  75. 75.
    Wright RA, Clemente R, Wathen R. Diabetic gastroparesis: an abnormality of gastric emptying of solids. Am J Med Sci 1985; 289(6): 240–2PubMedCrossRefGoogle Scholar
  76. 76.
    Maurer AH, Parkman HP. Update on gastrointestinal scintigraphy. Semin Nucl Med 2006; 36(2): 110–8PubMedCrossRefGoogle Scholar
  77. 77.
    Camilleri M, Hasler WL, Parkman HP, et al. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 1998; 115(3): 747–62PubMedCrossRefGoogle Scholar
  78. 78.
    Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol 2008; 36(1): 44–54PubMedCrossRefGoogle Scholar
  79. 79.
    Guo JP, Maurer AH, Fisher RS, et al. Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci 2001; 46(1): 24–9PubMedCrossRefGoogle Scholar
  80. 80.
    Ziessman HA, Bonta DV, Goetze S, et al. Experience with a simplified, standardized 4-hour gastric-emptying protocol. J Nucl Med 2007; 48(4): 568–72PubMedCrossRefGoogle Scholar
  81. 81.
    Bures J, Kopacova M, Vorisek V, et al. Examination of gastric emptying rate by means of 13C-octanoic acid breath test. Methods of the test for adults and results of the investigation of healthy volunteers. Cas Lek Cesk 2005; 144 Suppl. 3: 18–22Google Scholar
  82. 82.
    Chew CG, Bartholomeusz FD, Bellon M, et al. Simultaneous 13C/14C dual isotope breath test measurement of gastric emptying of solid and liquid in normal subjects and patients: comparison with scintigraphy. Nucl Med Rev Cent East Eur 2003; 6(1): 29–33PubMedGoogle Scholar
  83. 83.
    Sanaka M, Urita Y, Sugimoto M, et al. Comparison between gastric scintigraphy and the [13C]-acetate breath test with Wagner-Nelson analysis in humans. Clin Exp Pharmacol Physiol 2006; 33(12): 1239–43PubMedCrossRefGoogle Scholar
  84. 84.
    Sanaka M, Nakada K, Nosaka C, et al. The Wagner-Nelson method makes the [13C]-breath test comparable to radioscintigraphy in measuring gastric emptying of a solid/liquid mixed meal in humans. Clin Exp Pharmacol Physiol 2007; 34(7): 641–4PubMedCrossRefGoogle Scholar
  85. 85.
    Zahn A, Langhans CD, Hoffner S, et al. Measurement of gastric emptying by 13C-octanoic acid breath test versus scintigraphy in diabetics. Z Gastroenterol 2003; 41(5): 383–90PubMedCrossRefGoogle Scholar
  86. 86.
    Pfaffenbach B, Wegener M, Adamek RJ, et al. Non-invasive 13C octanoic acid breath test for measuring stomach emptying of a solid test meal-correlation with scintigraphy in diabetic patients and reproducibility in healthy probands. Z Gastroenterol 1995; 33(3): 141–5PubMedGoogle Scholar
  87. 87.
    Viramontes BE, Kim DY, Camilleri M, et al. Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying. Neurogastroenterol Motil 2001; 13(6): 567–74PubMedCrossRefGoogle Scholar
  88. 88.
    Haruma K, Kusunoki H, Manabe N, et al. Real-time assessment of gastroduodenal motility by ultrasonography. Digestion 2008; 77 Suppl. 1: 48–51CrossRefGoogle Scholar
  89. 89.
    Gentilcore D, Hausken T, Horowitz M, et al. Measurements of gastric emptying of low- and high-nutrient liquids using 3D ultrasonography and scintigraphy in healthy subjects. Neurogastroenterol Motil 2006; 18(12): 1062–8PubMedCrossRefGoogle Scholar
  90. 90.
    Gilja OH, Detmer PR, Jong JM, et al. Intragastric distribution and gastric emptying assessed by three-dimensional ultrasonography. Gastroenterology 1997; 113(1): 38–49PubMedCrossRefGoogle Scholar
  91. 91.
    Hveem K, Jones KL, Chatterton BE, et al. Scintigraphic measurement of gastric emptying and ultrasonographic assessment of antral area: relation to appetite. Gut 1996; 38(6): 816–21PubMedCrossRefGoogle Scholar
  92. 92.
    Stevens JE, Gilja OH, Gentilcore D, et al. Validation of 3D ultrasonography to measure gastric emptying of a high-nutrient drink in diabetic gastroparesis [abstract]. Gastroenterology 2008; 134 (4 Suppl. 1): A340Google Scholar
  93. 93.
    Kara S, Dirgenali F, Okkesim S. Detection of gastric dysrhythmia using WT and ANN in diabetic gastroparesis patients. Comput Biol Med 2006; 36(3): 276–90PubMedCrossRefGoogle Scholar
  94. 94.
    UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352(9131): 837–53CrossRefGoogle Scholar
  95. 95.
    O’Donovan D, Feinle-Bisset C, Jones K, et al. Idiopathic and diabetic gastroparesis. Curr Treat Options Gastroenterol 2003; 6(4): 299–309PubMedCrossRefGoogle Scholar
  96. 96.
    Gentilcore D, O’Donovan D, Jones KL, et al. Nutrition therapy for diabetic gastroparesis. Curr Diab Rep 2003; 3(5): 418–26PubMedCrossRefGoogle Scholar
  97. 97.
    Olausson EA, Alpsten M, Larsson A, et al. Small particle size of a solid meal increases gastric emptying and late postprandial glycaemic response in diabetic subjects with gastroparesis. Diabetes Res Clin Pract 2008; 80(2): 231–7PubMedCrossRefGoogle Scholar
  98. 98.
    Talley NJ. Diabetic gastropathy and prokinetics. Am J Gastroenterol 2003; 98(2): 264–71PubMedCrossRefGoogle Scholar
  99. 99.
    Horowitz M, Jones KL, Harding PE, et al. Relationship between the effects of cisapride on gastric emptying and plasma glucose concentrations in diabetic gastroparesis. Digestion 2002; 65(1): 41–6PubMedCrossRefGoogle Scholar
  100. 100.
    Petrakis IE, Vrachassotakis N, Sciacca V, et al. Hyperglycaemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in idiopathic and diabetic gastroparesis. Scand J Gastroenterol 1999; 34(4): 396–403PubMedCrossRefGoogle Scholar
  101. 101.
    Sturm A, Holtmann G, Goebell H, et al. Prokinetics in patients with gastroparesis: a systematic analysis. Digestion 1999; 60(5): 422–7PubMedCrossRefGoogle Scholar
  102. 102.
    Janssens J, Peeters TL, Vantrappen G, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin: preliminary studies. N Engl J Med 1990; 322(15): 1028–31PubMedCrossRefGoogle Scholar
  103. 103.
    Ehrenpreis ED, Zaitman D, Nellans H. Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis. Aliment Pharmacol Ther 1998; 12(4): 373–6PubMedCrossRefGoogle Scholar
  104. 104.
    Rayner CK, Horowitz M. New management approaches for gastroparesis. Nat Clin Pract Gastroenterol Hepatol 2005; 2(10): 454–62PubMedCrossRefGoogle Scholar
  105. 105.
    Richards RD, Davenport K, McCallum RW. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 1993; 88(2): 203–7PubMedGoogle Scholar
  106. 106.
    Dhir R, Richter JE. Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis. J Clin Gastroenterol 2004; 38(3): 237–42PubMedCrossRefGoogle Scholar
  107. 107.
    Ray WA, Murray KT, Meredith S, et al. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 2004; 351(11): 1089–96PubMedCrossRefGoogle Scholar
  108. 108.
    Sengupta S, Modak P, McCauley N, et al. Effect of oral clarithromycin on gall-bladder motility in normal subjects and those with gall-stones. Aliment Pharmacol Ther 2006; 24(1): 95–9PubMedCrossRefGoogle Scholar
  109. 109.
    Sutera L, Dominguez LJ, Belvedere M, et al. Azithromycin in an older woman with diabetic gastroparesis. Am J Ther 2008; 15(1): 85–8PubMedCrossRefGoogle Scholar
  110. 110.
    Rabine JC, Barnett JL. Management of the patient with gastroparesis. J Clin Gastroenterol 2001; 32(1): 11–8PubMedCrossRefGoogle Scholar
  111. 111.
    McCallum RW, Valenzuela G, Polepalle S, et al. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics. J Pharmacol Exp Ther 1991; 258(1): 136–42PubMedGoogle Scholar
  112. 112.
    McHugh S, Lico S, Diamant NE. Cisapride vs metoclopramide: an acute study in diabetic gastroparesis. Dig Dis Sci 1992; 37(7): 997–1001PubMedCrossRefGoogle Scholar
  113. 113.
    Tonini M, Cipollina L, Poluzzi E, et al. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther 2004; 19(4): 379–90PubMedCrossRefGoogle Scholar
  114. 114.
    Franzese A, Borrelli O, Corrado G, et al. Domperidone is more effective than cisapride in children with diabetic gastroparesis. Aliment Pharmacol Ther 2002; 16(5): 951–7PubMedCrossRefGoogle Scholar
  115. 115.
    Tatsuta M, Iishi H, Nakaizumi A, et al. Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 1992; 6(2): 221–8PubMedCrossRefGoogle Scholar
  116. 116.
    Abell TL, Camilleri M, DiMagno EP, et al. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 1991; 36(5): 616–20PubMedCrossRefGoogle Scholar
  117. 117.
    Veysey MJ, Malcolm P, Mallet AI, et al. Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial. Gut 2001; 49(6): 828–34PubMedCrossRefGoogle Scholar
  118. 118.
    Horowitz M, Maddern GJ, Maddox A, et al. Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis. Gastroenterology 1987; 93(2): 311–5PubMedGoogle Scholar
  119. 119.
    Kendall BJ, Kendall ET, Soykan I, et al. Cisapride in the long-term treatment of chronic gastroparesis: a 2-year open-label study. J Int Med Res 1997; 25(4): 182–9PubMedGoogle Scholar
  120. 120.
    Braden B, Enghofer M, Schaub M, et al. Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control. Aliment Pharmacol Ther 2002; 16(7): 1341–6PubMedCrossRefGoogle Scholar
  121. 121.
    Tonini M, De Ponti F, Di Nucci A, et al. Review article: cardiac adverse effects of gastrointestinal prokinetics. Aliment Pharmacol Ther 1999; 13(12): 1585–91PubMedCrossRefGoogle Scholar
  122. 122.
    Hasler WL. Gastroparesis: symptoms, evaluation, and treatment. Gastroenterol Clin North Am 2007; 36(3): 619–47, ixPubMedCrossRefGoogle Scholar
  123. 123.
    Itoh Z. Motilin and clinical application. Peptides 1997; 18(4): 593–608PubMedCrossRefGoogle Scholar
  124. 124.
    Verhagen MA, Samsom M, Maes B, et al. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. Aliment Pharmacol Ther 1997; 11(6): 1077–86PubMedCrossRefGoogle Scholar
  125. 125.
    Thielemans L, Depoortere I, Perret J, et al. Desensitization of the human motilin receptor by motilides. J Pharmacol Exp Ther 2005; 313(3): 1397–405PubMedCrossRefGoogle Scholar
  126. 126.
    Tack J, Peeters T. What comes after macrolides and other motilin stimulants? Gut 2001; 49(3): 317–8PubMedGoogle Scholar
  127. 127.
    McCallum RW, Cynshi O. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis. A randomized, multicentre, placebo-controlled study. Aliment Pharmacol Ther 2007; 26(8): 1121–30Google Scholar
  128. 128.
    McCallum RW, Cynshi O. Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial. Aliment Pharmacol Ther 2007; 26(1): 107–16PubMedCrossRefGoogle Scholar
  129. 129.
    Iwanaga Y, Kimura T, Miyashita N, et al. Characterization of acetylcholinesterase-inhibition by itopride. Jpn J Pharmacol 1994; 66(3): 317–22PubMedCrossRefGoogle Scholar
  130. 130.
    Holtmann G, Talley NJ, Liebregts T, et al. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006; 354(8): 832–40PubMedCrossRefGoogle Scholar
  131. 131.
    Talley NJ, Tack J, Ptak T, et al. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut 2008; 57(6): 740–6PubMedCrossRefGoogle Scholar
  132. 132.
    Stevens JE, Russo A, Maddox AF, et al. Effect of itopride on gastric emptying in longstanding diabetes mellitus. Neurogastroenterol Motil 2008; 20(5): 456–63PubMedCrossRefGoogle Scholar
  133. 133.
    Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 2005; 22(9): 847–53PubMedCrossRefGoogle Scholar
  134. 134.
    Murray CD, Martin NM, Patterson M, et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005; 54(12): 1693–8PubMedCrossRefGoogle Scholar
  135. 135.
    Zheng Q, Qiu WC, Yan J, et al. Prokinetic effects of a ghrelin receptor agonist GHRP-6 in diabetic mice. World J Gastroenterol 2008; 14(30): 4795–9PubMedCrossRefGoogle Scholar
  136. 136.
    Melga P, Mansi C, Ciuchi E, et al. Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis. Diabetes Care 1997; 20(1): 55–8PubMedCrossRefGoogle Scholar
  137. 137.
    Mansi C, Savarino V, Vigneri S, et al. Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis. Am J Gastroenterol 1995; 90(11): 1989–93PubMedGoogle Scholar
  138. 138.
    Degen L, Petrig C, Studer D, et al. Effect of tegaserod on gut transit in male and female subjects. Neurogastroenterol Motil 2005; 17(6): 821–6PubMedCrossRefGoogle Scholar
  139. 139.
    Morganroth J, Ruegg PC, Dunger-Baldauf C, et al. Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects. Am J Gastroenterol 2002; 97(9): 2321–7PubMedCrossRefGoogle Scholar
  140. 140.
    Dishy V, Cohen Pour M, Feldman L, et al. The effect of sildenafil on gastric emptying in patients with end-stage renal failure and symptoms of gastroparesis. Clin Pharmacol Ther 2004; 76(3): 281–6PubMedCrossRefGoogle Scholar
  141. 141.
    Bianco A, Pitocco D, Valenza V, et al. Effect of sildenafil on diabetic gastropathy. Diabetes Care 2002; 25(10): 1888–9PubMedCrossRefGoogle Scholar
  142. 142.
    Duby JJ, Campbell RK, Setter SM, et al. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm 2004; 61(2): 160–73PubMedGoogle Scholar
  143. 143.
    Tolle T, Freynhagen R, Versavel M, et al. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study. Eur J Pain 2008; 12(2): 203–13PubMedCrossRefGoogle Scholar
  144. 144.
    Feinle C, Meier O, Otto B, et al. Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001; 48(3): 347–55PubMedCrossRefGoogle Scholar
  145. 145.
    Lin ZY, McCallum RW, Schirmer BD, et al. Effects of pacing parameters on entrainment of gastric slow waves in patients with gastroparesis. Am J Physiol 1998; 274(1 Pt 1): G186–91PubMedGoogle Scholar
  146. 146.
    McCallum RW, Chen JD, Lin Z, et al. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology 1998; 114(3): 456–61PubMedCrossRefGoogle Scholar
  147. 147.
    Lin Z, Forster J, Sarosiek I, et al. Effect of high-frequency gastric electrical stimulation on gastric myoelectric activity in gastroparetic patients. Neurogastroenterol Motil 2004; 16(2): 205–12PubMedCrossRefGoogle Scholar
  148. 148.
    Lin Z, Hou Q, Sarosiek I, et al. Association between changes in symptoms and gastric emptying in gastroparetic patients treated with gastric electrical stimulation. Neurogastroenterol Motil 2008; 20(5): 464–70PubMedCrossRefGoogle Scholar
  149. 149.
    Abell TL, Van Cutsem E, Abrahamsson H, et al. Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion 2002; 66(4): 204–12PubMedCrossRefGoogle Scholar
  150. 150.
    Zhang J, Chen JD. Systematic review: applications and future of gastric electrical stimulation. Aliment Pharmacol Ther 2006; 24(7): 991–1002PubMedCrossRefGoogle Scholar
  151. 151.
    Ayinala S, Batista O, Goyal A, et al. Temporary gastric electrical stimulation with orally or PEG-placed electrodes in patients with drug refractory gastroparesis. Gastrointest Endosc 2005; 61(3): 455–61PubMedCrossRefGoogle Scholar
  152. 152.
    Elfvin A, Andersson S, Abrahamsson H, et al. Percutaneous implantation of gastric electrodes: a novel technique applied in animals and in patients. Neurogastroenterol Motil 2007; 19(2): 103–9PubMedCrossRefGoogle Scholar
  153. 153.
    Sallam HS, Chen JD, Pasricha PJ. Feasibility of gastric electrical stimulation by percutaneous endoscopic transgastric electrodes. Gastrointest Endosc 2008; 68(4): 754–9PubMedCrossRefGoogle Scholar
  154. 154.
    Xu X, Pasricha PJ, Chen JD. Feasibility of gastric electrical stimulation by use of endoscopically placed electrodes. Gastrointest Endosc 2007; 66(5): 981–6PubMedCrossRefGoogle Scholar
  155. 155.
    Abell TL, Malinowski S, Minocha A. Nutrition aspects of gastroparesis and therapies for drug-refractory patients. Nutr Clin Pract 2006; 21(1): 23–33PubMedCrossRefGoogle Scholar
  156. 156.
    Anand C, Al-Juburi A, Familoni B, et al. Gastric electrical stimulation is safe and effective: a long-term study in patients with drug-refractory gastroparesis in three regional centers. Digestion 2007; 75(2–3): 83–9PubMedCrossRefGoogle Scholar
  157. 157.
    Cutts TF, Luo J, Starkebaum W, et al. Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits? Neurogastroenterol Motil 2005; 17(1): 35–43PubMedCrossRefGoogle Scholar
  158. 158.
    Maranki JL, Lytes V, Meilahn JE, et al. Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis. Dig Dis Sci 2008; 53(8): 2072–8PubMedCrossRefGoogle Scholar
  159. 159.
    McCallum RW, Dusing RW, Sarosiek I, et al. Mechanisms of high-frequency electrical stimulation of the stomach in gastroparetic patients. Conf Proc IEEE Eng Med Biol Soc 2006; 1: 5400–3PubMedGoogle Scholar
  160. 160.
    Abell TL. Gastric electric stimulation is a viable option in gastroparesis treatment. Nat Clin Pract Gastroenterol Hepatol 2009; 6(3): E8–13PubMedCrossRefGoogle Scholar
  161. 161.
    Jones MP. Is gastric electrical stimulation an effective therapy for patients with drug-refractory gastroparesis? Nat Clin Pract Gastroenterol Hepatol 2008; 5(7): 368–70PubMedCrossRefGoogle Scholar
  162. 162.
    Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991; 324(17): 1186–94PubMedCrossRefGoogle Scholar
  163. 163.
    Pasricha PJ, Ravich WJ, Hendrix TR, et al. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995; 332(12): 774–8PubMedCrossRefGoogle Scholar
  164. 164.
    Lacy BE, Crowell MD, Schettler-Duncan A, et al. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care 2004; 27(10): 2341–7PubMedCrossRefGoogle Scholar
  165. 165.
    Miller LS, Szych GA, Kantor SB, et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002; 97(7): 1653–60PubMedCrossRefGoogle Scholar
  166. 166.
    Ezzeddine D, Jit R, Katz N, et al. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 2002; 55(7): 920–3PubMedCrossRefGoogle Scholar
  167. 167.
    Lacy BE, Zayat EN, Crowell MD, et al. Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol 2002; 97(6): 1548–52PubMedCrossRefGoogle Scholar
  168. 168.
    Arts J, Holvoet L, Caenepeel P, et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007; 26(9): 1251–8PubMedCrossRefGoogle Scholar
  169. 169.
    Friedenberg FK, Palit A, Parkman HP, et al. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 2008; 103(2): 416–23PubMedCrossRefGoogle Scholar
  170. 170.
    Wang L. Clinical observation on acupuncture treatment in 35 cases of diabetic gastroparesis. J Tradit Chin Med 2004; 24(3): 163–5PubMedGoogle Scholar
  171. 171.
    Wang CP, Kao CH, Chen WK, et al. A single-blinded, randomized pilot study evaluating effects of electroacupuncture in diabetic patients with symptoms suggestive of gastroparesis. J Altern Complement Med 2008; 14(7): 833–9PubMedCrossRefGoogle Scholar
  172. 172.
    Wang XY, Shi X, He L. Effect of electroacupuncture on gastrointestinal dynamics in acute pancreatitis patients and its mechanism. Zhen Ci Yan Jiu 2007; 32(3): 199–202PubMedGoogle Scholar
  173. 173.
    Jones MP, Maganti K. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol 2003; 98(10): 2122–9PubMedCrossRefGoogle Scholar
  174. 174.
    Cashion AK, Holmes SL, Hathaway DK, et al. Gastroparesis following kidney/pancreas transplant. Clin Transplant 2004; 18(3): 306–11PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2009

Authors and Affiliations

  • Jing Ma
    • 1
    • 2
  • Christopher K. Rayner
    • 1
    • 2
    Email author
  • Karen L. Jones
    • 2
  • Michael Horowitz
    • 1
    • 2
  1. 1.Royal Adelaide HospitalUniversity of Adelaide Discipline of MedicineAdelaideAustralia
  2. 2.Centre of Clinical Research Excellence in Nutritional PhysiologyAdelaideAustralia

Personalised recommendations